Will This Drugmaker Hit a Roadblock?

Diabetes drug Januvia has been a boon for Merck (NYSE: MRK  ) in recent years, and its massive year-over-year growth was one way the company was able to offset the  huge losses incurred by Singulair's recent patent expiration. Recently, however, a study published in JAMA Internal Medicine showed that patients on Januvia and a different diabetes drug -- Byetta, which is jointly marketed by Bristol-Myers Squibb (NYSE: BMY  ) and AstraZeneca (NYSE: AZN  )  -- are more at risk of developing pancreatitis.

The risk of pancreatitis with these drugs was already known to a certain extent, and, despite this study, it doesn't seem likely these drugs will be pulled from the market -- but what would happen if they are? Focusing just on Januvia, how dependent has Merck become on this drug? Health care analyst Max Macaluso discusses this situation in the following video.

Can Merck beat the patent cliff?
This titan of the pharmaceutical industry stumbled into 2013 and continues to battle patent expirations and pipeline problems. Is Merck still a solid dividend play, or should investors be looking elsewhere? In a new premium research report on Merck, The Fool tackles all of the company's moving parts, its major market opportunities, and reasons to both buy and sell. To find out more click here to claim your copy today.



Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

DocumentId: 2301521, ~/Articles/ArticleHandler.aspx, 7/31/2014 2:41:59 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 5 hours ago Sponsored by:
DOW 16,880.36 -31.75 -0.19%
S&P 500 1,970.07 0.12 0.01%
NASD 4,462.90 20.20 0.45%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

7/30/2014 4:01 PM
MRK $58.08 Down -0.50 -0.85%
Merck & Co., Inc. CAPS Rating: ***
AZN $73.19 Up +0.08 +0.11%
AstraZeneca plc (A… CAPS Rating: ***
BMY $51.12 Up +0.11 +0.22%
Bristol-Myers Squi… CAPS Rating: ****

Advertisement